Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary carcinoma of the larynx.

Oral oncology - 1 Dec 2009

Sahoo R, Chittibabu V, Patil G, Rao S, Thakur S, Dhondalay G, Kulkarni A J, Banerjee A, Ajaikumar B S, Korlimarla A, Nargund A, Niti R N, Gopinath K S, Prabhudesai Shilpa, Raghavendra R M

Abstract excerpt

p53 Mutations and over expression have been shown to predict treatment response in head and neck cancer patients. Failure of organ sparing therapy has been attributed to cisplatin and radiotherapy resistance in carcinoma of the larynx patients. In this study, we evaluate the relationships between p53 over expression/mutations, bcl(2) expression and ploidy status in a retrospective cohort of responder and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Genes, bcl-2

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Laryngeal Neoplasms

Share to Ploidies

Share to Proto-Oncogene Proteins c-bcl-2

Share to Smoking

Source

Identifiers

PMID: 19729336
DOI: 10.1016/j.oraloncology.2009.07.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary carcinoma of the larynx.PMID 19729336Read ↗

Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent.Semantic proximity Read ↗

Overexpression of Bcl‐2 in squamous cell carcinoma of the larynx: A marker of radioresistanceSemantic proximity Read ↗

TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

p53 mutation, but not in vitro predictor genes of therapeutic efficacy of cisplatin, is clinically relevant in comparing partial and complete responder cases of maxillary squamous cell carcinoma.Semantic proximity Read ↗

Patterns of p53 gene mutations in head and neck cancer: full-length gene sequencing and results of primary radiotherapy.Semantic proximity Read ↗

Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.Semantic proximity Read ↗

Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53.Semantic proximity Read ↗

p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation.Semantic proximity Read ↗

Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk.Semantic proximity Read ↗

Evaluation of p53 protein as a prognostic factor for oral cancer surgery.Semantic proximity Read ↗

Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy.Semantic proximity Read ↗

[p53 mutations and chemoresistance in oromaxillofacial squamous-cell carcinomas. The results of a molecular genetics study of p53 in metastatic oromaxillofacial tumors and an evaluation of the response to neoadjuvant chemotherapeutic treatment].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.